General MedicationsINJECTIONStandard

MAGNESIUM SULFATE

Standard Dose

3GM/100ML (30MG/ML)

Max Dose

Refer to approved labeling

Primary Use

Review priority: UNKNOWN Marketing status: Prescription

Summary

Approval overview MAGNESIUM SULFATE is listed in Drugs@FDA under application 211966 (ANDA).

Review priority: UNKNOWN Marketing status: Prescription Active ingredient MAGNESIUM SULFATE Form and strength INJECTABLE;INJECTION - 3GM/100ML (30MG/ML) Sponsor BAXTER HLTHCARE CORP Submission history Latest submission status date: 2026-01-08 00:00:00.

Structured Monograph

Clinical summary

Approval overview MAGNESIUM SULFATE is listed in Drugs@FDA under application 211966 (ANDA). Review priority: UNKNOWN Marketing status: Prescription Active ingredient MAGNESIUM SULFATE Form and strength INJECTABLE;INJECTION - 3GM/100ML (30MG/ML) Sponsor BAXTER HLTHCARE CORP Submission history Latest submission status date: 2026-01-08 00:00:00. Submission type: SUPPL.

Monitoring

• Marketing status: Prescription
• Review priority: UNKNOWN

Interaction Notes

No interaction notes stored yet.